Peptide-functionalized iron oxide nanoparticles enable multi-modal cancer therapy combining magnetic targeting, drug delivery, MRI imaging, and hyperthermia through peptide-guided tumor specificity.
One platform, four functionsPeptide-functionalized iron oxide nanoparticles simultaneously target tumors, deliver drugs, provide imaging, and heat cancer cells — the ultimate multi-tool
What the researchers found
Peptide-functionalized iron oxide NPs: multi-modal cancer therapy combining magnetic targeting, drug delivery, MRI imaging, and hyperthermia through peptide-guided tumor specificity.
Why it matters
Multi-modal cancer therapy from a single platform — diagnose, target, and treat with one nanoparticle system.
How the study worked
Review of peptide-functionalized iron oxide nanoparticle targeting strategies and multi-modal cancer therapy applications.
What this study cannot tell us
Most applications preclinical. Iron oxide NP regulatory approval complex.
How to read the evidence
Review of multi-modal cancer therapy applications.
When this study was published
Published in 2025.
The bigger picture
Peptide-targeted theranostic nanoparticles represent the convergence of imaging, drug delivery, and physical therapy in a single platform.
Questions still open
- Which peptide provides the best tumor targeting for iron oxide NPs?
- Would combining multiple targeting peptides improve tumor specificity?
- How close are peptide-iron oxide NP theranostics to clinical use?
Common questions
What can peptide-iron oxide nanoparticles do for cancer?
How do peptides help?
Read the original research
Peptide-Functionalized Iron Oxide Nanoparticles for Cancer Therapy: Targeting Strategies, Mechanisms, and Translational Opportunities.
Molecules (Basel, Switzerland), 31(2)
Citation
Kuskov, Andrey N; Thrapsanioti, Lydia-Nefeli; Kukovyakina, Ekaterina; Yagolovich, Anne; Vlaskina, Elizaveta; Tzanakakis, Petros; Berdiaki, Aikaterini; Nikitovic, Dragana. (2026). Peptide-Functionalized Iron Oxide Nanoparticles for Cancer Therapy: Targeting Strategies, Mechanisms, and Translational Opportunities.. Molecules (Basel, Switzerland), 31(2). https://doi.org/10.3390/molecules31020236